5CUI TG,HOU FF,NIZH,et al.Treament of p roliferative lupus nephritiswith leflunomide and steroid:a p rospective multicenter controlled clinical trial[J].Zhonghua Nei Ke Za Zhi,2005,44 (9):672-676.
二级参考文献22
1Illei GG,Austin HA,Crane M,et al.Combination therapy Withpulse cyclophosphamide plus pulse methylprednisolone iPEroveslong-term renal outcome without adding toxicity in patients with lupus nephritis.Ann Intern Med,2001,135:248-257.
2Gorman C,Bhatia A,Rahman A.This house believes that lowdose intravenous cyclophosphamide is superior to standard highdose regimens for treatment of lupus nephritis.Rheumatology,2005,44:398-401.
3Houssiau FA,Vasconcelos C,DCruz D,et al.Immunosuppressivetherapy in lupus nephritis.Arthritis Rheum,2002,46:2121-2131.
4Goldblatt F,Isenberg DA.New therapies for systemic lupus erythematosus[J].Clinical and Experimental Immunology,2005,140:205-212.
5Abu-Shakra M,Shoenfeld Y.Azathioprine therapy for patients with systemic lupus erythematosus[J].Lupus,2001,10:152-153.
6Chan TM,Li FK,Tang CSO,et al.Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis[J].N Engl J Med,2000,343:1156-1162.
8Spetie DN,Tang Y,Rovin BH,et al.Mycophenolate therapy of SLE membranous nephropathy[M].7th International Conference on SLE and Related Conditions.Abstract W53A.2004.
9Toubi E,Kessel A,Shoenfeld Y.High-dose intravenous immunoglobulins:an option in the treatment of systemic lupus erythematosus[J].Human Immunology,2005,66:395-402.
